Report cover image

APAC Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Publisher Data Bridge Market Research
Published May 01, 2022
Length 183 Pages
SKU # DAABD17330399

Description

APAC Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Asia-Pacific psychedelic drugs market is projected to register a healthy CAGR of 11.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Asia-Pacific Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) Country (India, Australia, South Korea, Singapore, Malaysia and Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific psychedelic drugs market are:
• Due to growing clinical trials in the market
• Growing Acceptance Of Psychedelic Drugs For Treating Depression

Market Players

The key market players for Asia-Pacific psychedelic drugs market are listed below:
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd

Table of Contents

183 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia Pacific Psychedelic Drugs Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Pipeline Analysis
4.2 Pestel Analysis
4.3 Porter's Five Forces Model
5 Regulatory Framework: Asia Pacific Psychedelic Drugs Market
5.1 Regulatory Scenario In The U.S.
5.2 Regulatory Scenario In The U.K.
5.3 Regulatory Scenario In India
5.4 Regulatory Scenario In Uae
5.5 Regulatory Scenario In Africa
5.6 Regulatory Scenario In Brazil
6 Market Overview
6.1 Drivers
6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression
6.1.2 Increasing Prevalence Of Depression And Mental Disorders
6.1.3 Rising Awareness Toward Mental Health
6.1.4 Ongoing Clinical Trials
6.1.5 Rise In Product Approvals
6.2 Restraints
6.2.1 Stringent Regulations For Psychedelic Drugs
6.2.2 High Cost Of Psychedelic Drugs
6.2.3 Patent Expiry Of Psychedelic Drugs
6.3 Opportunities
6.3.1 Increasing R&D Activities In Psychedelic Drugs
6.3.2 Breakthrough Therapy Designation By Regulatory Authority
6.3.3 Upcoming Rehabilitation Centers
6.3.4 Availability Of Certified Healthcare Professionals
6.4 Challenges
6.4.1 Side Effects Associated With Psychedelic Drugs
6.4.2 Rise In Illegal Alternatives
6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The Asia Pacific Psychedelic Drugs Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Strategic Decisions For Manufacturers
7.5 Conclusion
8 Asia Pacific Psychedelic Drugs Market, By Type
8.1 Overview
8.2 Empathogens
8.3 Dissociatives
8.4 Others
9 Asia Pacific Psychedelic Drugs Market, By Source
9.1 Overview
9.2 Synthetic
9.3 Natural
10 Asia Pacific Psychedelic Drugs Market, By Drugs
10.1 Overview
10.2 Gamma-hydroxybutyric Acid
10.3 Ketamine
10.4 Psilocybin
10.5 Others
11 Asia Pacific Psychedelic Drugs Market, By Application
11.1 Overview
11.2 Narcolepsy
11.3 Treatment Resistant Depression
11.4 Major Depressive Disorder
11.5 Opiate Addiction
11.6 Post-traumatic Stress Disorder
11.7 Others
12 Asia Pacific Psychedelic Drugs Market, By Route Of Administration
12.1 Overview
12.2 Oral
12.3 Inhalation
12.4 Injectable
13 Asia Pacific Psychedelic Drugs Market, By End User
13.1 Overview
13.2 Hospitals
13.3 Specialty Clinics
13.4 Homecare
13.5 Others
14 Asia Pacific Psychedelic Drugs Market, By Distribution Channel
14.1 Overview
14.2 Hospitals Pharmacy
14.3 Retail Pharmacy
14.4 Online Pharmacy
15 Asia Pacific Psychedelic Drugs Market, By Region
15.1 Asia-pacific
15.1.1 India
15.1.2 Australia
15.1.3 South Korea
15.1.4 Singapore
15.1.5 Malaysia
16 Asia Pacific Psychedelic Drugs Market: Company Landscape
16.1 Company Share Analysis: Asia Pacific
17 Swot Analysis
18 Company Profile
18.1 Jazz Pharmaceuticals, Inc.
18.1.1 Company Snapshot
18.1.2 Revenue Analysis
18.1.3 Company Share Analysis
18.1.4 Product Portfolio
18.1.5 Recent Developments
18.2 Pfizer Inc.
18.2.1 Company Snapshot
18.2.2 Revenue Analysis
18.2.3 Company Share Analysis
18.2.4 Product Portfolio
18.2.5 Recent Developments
18.3 F. Hoffmann- La Roche Ltd
18.3.1 Company Snapshot
18.3.2 Revenue Analysis
18.3.3 Company Share Analysis
18.3.4 Product Portfolio
18.3.5 Recent Development
18.4 Janssen Asia Pacific Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.)
18.4.1 Company Snapshot
18.4.2 Company Share Analysis
18.4.3 Product Portfolio
18.4.4 Recent Development
18.5 Avadel
18.5.1 Company Snapshot
18.5.2 Product Portfolio
18.5.3 Recent Development
18.6 Celon Pharma Sa
18.6.1 Company Snapshot
18.6.2 Product Portfolio
18.6.3 Recent Development
18.7 Compass
18.7.1 Company Snapshot
18.7.2 Product Portfolio
18.7.3 Recent Developments
18.8 Cybin Corp.
18.8.1 Company Snapshot
18.8.2 Product Portfolio
18.8.3 Recent Developments
18.9 Entheon Biomedical Corp
18.9.1 Company Snapshot
18.9.2 Product Portfolio
18.9.3 Recent Development
18.10 Gh Research
18.10.1 Company Snapshot
18.10.2 Product Portfolio
18.10.3 Recent Development
18.11 Hikma Pharmaceuticals Plc
18.11.1 Company Snapshot
18.11.2 Revenue Analysis
18.11.3 Product Portfolio
18.11.4 Recent Developments
18.12 Nrx Pharmaceuticals, Inc.
18.12.1 Company Snapshot
18.12.2 Product Portfolio
18.12.3 Recent Development
18.13 Pharmather Holdings Ltd.
18.13.1 Company Snapshot
18.13.2 Product Portfolio
18.13.3 Recent Development
18.14 Verrian
18.14.1 Company Snapshot
18.14.2 Product Portfolio
18.14.3 Recent Development
18.15 Usonainstitute.Org
18.15.1 Company Snapshot
18.15.2 Product Portfolio
18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables
Table 1 Asia Pacific Psychedelic Drugs Market, Pipeline Analysis
Table 2 Psychedelics Research Studies, In Europe
Table 3 Mental Illness In The U.S. Adults, In 2020
Table 4 Mental Disorders, In The U.S. Adults, In 2020
Table 5 Drug Development Pathway For Fda Approval Of New Medications
Table 6 The 1971 Un Convention On Psychotropic Substances
Table 7 Magic Mushrooms Prices For Researchers, In The U.S.
Table 8 Cost Of Psychedelic Drugs
Table 9 Psychedelic Drugs R&D Activities
Table 10 Asia Pacific Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 11 Asia Pacific Empathogens In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 12 Asia Pacific Dissociatives In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 13 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 14 Asia Pacific Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 15 Asia Pacific Synthetic In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 16 Asia Pacific Natural In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 17 Asia Pacific Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 18 Asia Pacific Gamma-hydroxybutyric Acid In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 19 Asia Pacific Ketamine In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 20 Asia Pacific Psilocybin In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 21 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 22 Asia Pacific Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 23 Asia Pacific Narcolepsy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 24 Asia Pacific Treatment Resistant Depression In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 25 Asia Pacific Major Depressive Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 26 Asia Pacific Opiate Addiction In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 27 Asia Pacific Post-traumatic Stress Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 28 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 29 Asia Pacific Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 30 Asia Pacific Oral In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 31 Asia Pacific Inhalation In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 32 Asia Pacific Injectable In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 33 Asia Pacific Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 34 Asia Pacific Hospitals In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 35 Asia Pacific Specialty Clinics In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 36 Asia Pacific Homecare In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 37 Asia Pacific Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 38 Asia Pacific Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 39 Asia Pacific Hospitals Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 40 Asia Pacific Retail Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 41 Asia Pacific Online Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million)
Table 42 Asia-pacific Psychedelic Drugs Market, By Country, 2020-2029 (Usd Million)
Table 43 Asia-pacific Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 44 Asia-pacific Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 45 Asia-pacific Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 46 Asia-pacific Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 47 Asia-pacific Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 48 Asia-pacific Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 49 Asia-pacific Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 50 India Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 51 India Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 52 India Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 53 India Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 54 India Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 55 India Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 56 India Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 57 Australia Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 58 Australia Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 59 Australia Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 60 Australia Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 61 Australia Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 62 Australia Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 63 Australia Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 64 South Korea Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 65 South Korea Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 66 South Korea Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 67 South Korea Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 68 South Korea Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 69 South Korea Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 70 South Korea Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 71 Singapore Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 72 Singapore Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 73 Singapore Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 74 Singapore Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 75 Singapore Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 76 Singapore Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 77 Singapore Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 78 Malaysia Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
Table 79 Malaysia Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million)
Table 80 Malaysia Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million)
Table 81 Malaysia Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million)
Table 82 Malaysia Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million)
Table 83 Malaysia Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million)
Table 84 Malaysia Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures
Figure 1 Asia Pacific Psychedelic Drugs Market: Segmentation
Figure 2 Asia Pacific Psychedelic Drugs Market : Data Triangulation
Figure 3 Asia Pacific Psychedelic Drugs Market: Droc Analysis
Figure 4 Asia Pacific Psychedelic Drugs Market: Asia Pacific Vs Regional Market Analysis
Figure 5 Asia Pacific Psychedelic Drugs Market: Company Research Analysis
Figure 6 Asia Pacific Psychedelic Drugs Market: Multivariate Modelling
Figure 7 Asia Pacific Psychedelic Drugs Market: Interview Demographics
Figure 8 Asia Pacific Psychedelic Drugs Market: Dbmr Market Position Grid
Figure 9 Asia Pacific Psychedelic Drugs Market: End User Coverage Grid
Figure 10 Asia Pacific Psychedelic Drugs Market: Vendor Share Analysis
Figure 11 Asia Pacific Psychedelic Drugs Market: Segmentation
Figure 12 North America Is Expected To Dominate The Asia Pacific Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029
Figure 13 Rising Awareness Towards Merantal Health Driving The Asia Pacific Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029
Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The Asia Pacific Psychedelic Drugs Market In 2022 & 2029
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Psychedelic Drugs Market
Figure 16 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 17 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups
Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender
Figure 19 Asia Pacific Psychedelic Drugs Market: By Type, 2021
Figure 20 Asia Pacific Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million)
Figure 21 Asia Pacific Psychedelic Drugs Market: By Type, Cagr (2022-2029)
Figure 22 Asia Pacific Psychedelic Drugs Market: By Type, Lifeline Curve
Figure 23 Asia Pacific Psychedelic Drugs Market: By Source, 2021
Figure 24 Asia Pacific Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million)
Figure 25 Asia Pacific Psychedelic Drugs Market: By Source, Cagr (2022-2029)
Figure 26 Asia Pacific Psychedelic Drugs Market: By Source, Lifeline Curve
Figure 27 Asia Pacific Psychedelic Drugs Market: By Drugs, 2021
Figure 28 Asia Pacific Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million)
Figure 29 Asia Pacific Psychedelic Drugs Market: By Drugs, Cagr (2022-2029)
Figure 30 Asia Pacific Psychedelic Drugs Market: By Drugs, Lifeline Curve
Figure 31 Asia Pacific Psychedelic Drugs Market: By Application, 2021
Figure 32 Asia Pacific Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million)
Figure 33 Asia Pacific Psychedelic Drugs Market: By Application, Cagr (2022-2029)
Figure 34 Asia Pacific Psychedelic Drugs Market: By Application, Lifeline Curve
Figure 35 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, 2021
Figure 36 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million)
Figure 37 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029)
Figure 38 Asia Pacific Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve
Figure 39 Asia Pacific Psychedelic Drugs Market: By End User, 2021
Figure 40 Asia Pacific Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million)
Figure 41 Asia Pacific Psychedelic Drugs Market: By End User, Cagr (2022-2029)
Figure 42 Asia Pacific Psychedelic Drugs Market: By End User, Lifeline Curve
Figure 43 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, 2021
Figure 44 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million)
Figure 45 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029)
Figure 46 Asia Pacific Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve
Figure 47 Asia-pacific Psychedelic Drugs Market: Snapshot (2021)
Figure 48 Asia-pacific Psychedelic Drugs Market: By Country (2021)
Figure 49 Asia-pacific Psychedelic Drugs Market: By Country (2022 & 2029)
Figure 50 Asia-pacific Psychedelic Drugs Market: By Country (2021 & 2029)
Figure 51 Asia-pacific Psychedelic Drugs Market: By Type (2022-2029)
Figure 52 Asia Pacific Psychedelic Drugs Market: Company Share 2021 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us